Understanding Relapsing Polychondritis
Relapsing polychondritis is a rare, systemic autoimmune disorder characterized by recurrent inflammation and destruction of cartilaginous structures throughout the body. The most commonly affected areas include the ears, nose, joints, and the tracheobronchial tree. Because cartilage is avascular and immunologically privileged, its involvement in an autoimmune process can lead to progressive tissue damage and organ dysfunction if treatment is delayed.
The disease may present in isolation or overlap with other autoimmune conditions. While the exact trigger remains unknown, both humoral and cellular immune mechanisms are believed to attack cartilage-specific antigens, including collagens type II, IX, and XI. This autoimmune attack results in chondritis, which can be mistaken for infection or trauma in its early stages.
Cogan's Syndrome and Its Overlap
A closely related and often overlapping condition is Cogan's syndrome, an autoimmune vasculitis that classically presents with interstitial keratitis and audiovestibular dysfunction. In clinical practice, the distinction between relapsing polychondritis and Cogan's syndrome can be challenging, as both may involve the eye, ear, and systemic vessels. Some authors consider Cogan's syndrome to be a variant of relapsing polychondritis when auricular chondritis is present alongside the classic ocular and inner ear findings.
Patients with either diagnosis require prompt recognition because audiovestibular involvement can result in permanent hearing loss and severe balance impairment. The presence of Cogan's-like features in a patient with relapsing polychondritis often portends a more aggressive course and warrants early aggressive immunosuppression.
A Case Presentation Illustrating the Challenges
A case worth considering involves a 45-year-old patient who presented with a two-week history of painful redness and swelling of both ears, followed by the sudden onset of vertigo and rapidly progressive hearing loss in one ear. Initial evaluation suggested otitis externa, but the lack of response to antibiotics and the development of audiometric abnormalities prompted further investigation.
Physical examination revealed erythema and edema of the pinnae with sparing of the lobules, a finding consistent with auricular chondritis. Hearing assessment confirmed a moderate sensorineural hearing loss on the affected side. Vestibular testing demonstrated reduced caloric responses, indicating peripheral vestibular loss. Laboratory studies showed an elevated erythrocyte sedimentation rate and positive anti-collagen type II antibodies. The patient fulfilled diagnostic criteria for relapsing polychondritis and also exhibited features suggestive of Cogan's syndrome.
This case highlights how overlapping presentations can occur. The combination of ocular symptoms, which developed later in the form of mild red eyes, and audiovestibular dysfunction raised concern for Cogan's syndrome. Treatment with high-dose corticosteroids was initiated, followed by steroid-sparing immunosuppressive therapy, leading to stabilization of hearing and gradual improvement in balance function.
Autoimmune Basis and Pathophysiology
The autoimmune nature of relapsing polychondritis is supported by its association with HLA-DR4 and the presence of antibodies directed against cartilage proteins. T-cell infiltration in affected cartilage demonstrates a dominant Th1 response, and cytokines such as tumor necrosis factor-alpha play a central role in tissue destruction. In the inner ear, this autoimmune attack may target the membranous labyrinth, leading to cochlear hair cell loss and damage to vestibular end organs.
Hearing loss in relapsing polychondritis is typically sudden or rapidly progressive, often bilateral but asymmetric. It can be sensorineural, conductive, or mixed. Conductive components may arise from inflammation of the eustachian tube or ossicular cartilage, while sensorineural loss results from cochlear involvement. Vestibular loss is also common and may manifest as episodic vertigo, positional instability, or chronic disequilibrium.
Clinical Features of Hearing and Vestibular Loss
Hearing loss is one of the most serious complications of relapsing polychondritis, occurring in approximately one-third of patients. When the disease also presents with features of Cogan's syndrome, the likelihood of audiovestibular symptoms increases significantly. The hearing loss may precede the onset of chondritis by weeks or months, making early diagnosis difficult.
Vestibular loss in this setting is often underappreciated. Some patients complain of a vague sensation of unsteadiness rather than true vertigo. Objective testing, including videonystagmography and caloric examination, may reveal reduced vestibular responses. In advanced cases, bilateral vestibular loss can lead to oscillopsia and difficulty walking in the dark, severely impairing quality of life.
Early recognition of the autoimmune cause is critical, as irreversible damage to auditory and vestibular structures can occur within weeks. Magnetic resonance imaging with gadolinium may show enhancement of the cochlea or vestibule, supporting the diagnosis of autoimmune inner ear disease.
Diagnostic Considerations
Relapsing polychondritis is diagnosed based on the McAdam criteria, which include bilateral auricular chondritis, nonerosive seronegative inflammatory polyarthritis, nasal chondritis, ocular inflammation, respiratory tract chondritis, and audiovestibular damage. The presence of three or more features is required for a definite diagnosis. A case with coexisting Cogan's syndrome may be identified by interstitial keratitis in addition to ear involvement.
No single laboratory test confirms the diagnosis. Biopsy of affected cartilage shows loss of basophilic staining, perichondrial inflammation, and fibrous replacement. However, biopsy is not always necessary when clinical features are typical.
Treatment Approaches
Corticosteroids remain the mainstay of therapy for acute flares and for preservation of hearing and vestibular function. In patients with progressive disease or steroid dependence, immunosuppressive agents such as methotrexate, azathioprine, and mycophenolate mofetil are commonly used. Biologic agents, including tumor necrosis factor inhibitors and rituximab, have shown promise in refractory cases, particularly when there is significant audiovestibular involvement.
Supportive measures for hearing loss include hearing aids and cochlear implantation in cases of profound bilateral loss. For patients with vestibular loss, vestibular rehabilitation therapy can promote central compensation and improve gait stability.
Prognosis and Long-Term Outcomes
The prognosis of relapsing polychondritis varies widely. When limited to auricular and nasal cartilage, the disease may have a more indolent course. However, involvement of the respiratory tract, cardiovascular system, or inner ear is associated with increased morbidity and mortality. Early and aggressive treatment is associated with better preservation of audiovestibular function.
In patients whose disease overlaps with Cogan's syndrome, the audiovestibular damage can be particularly severe. Long-term follow-up is required to monitor for late relapses and to adjust immunosuppressive therapy as needed.
Conclusion
Relapsing polychondritis is a complex autoimmune disorder that can have devastating effects on hearing and balance. When clinical features of Cogan's syndrome are present, the index of suspicion for audiovestibular involvement should be even higher, as seen in the case presented above. Prompt recognition of the autoimmune etiology, early initiation of immunosuppressive treatment, and comprehensive audiometric and vestibular assessment are essential to minimize permanent disability.
Clinicians should maintain a low threshold for considering these diagnoses in any patient presenting with unexplained hearing loss and vertigo, especially when accompanied by inflammation of cartilage or the eyes. Multidisciplinary care, involving rheumatology, otolaryngology, and audiology, offers the best chance for preserving both hearing and vestibular function.